Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mariann Polgar-Turcsanyi"'
Autor:
Evan Madill, Brian C. Healy, Negar Molazadeh, Mariann Polgar‐Turcsanyi, Bonnie I. Glanz, Howard L. Weiner, Tanuja Chitnis
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 10, Pp 2719-2730 (2024)
Abstract Objective Glial fibrillary acidic protein (GFAP) is expressed in astrocytes and may be a useful marker of non‐active progressive multiple sclerosis (MS). We evaluate serum GFAP (sGFAP) in a large cohort of MS patients to determine if it pr
Externí odkaz:
https://doaj.org/article/966a08e2c53e4a22b825ebb28ba94705
Autor:
Alicia Gonzalez-Martinez, Gauruv Bose, Hrishikesh Lokhande, Shrishti Saxena, Brian C. Healy, Mariann Polgar-Turcsanyi, Howard L. Weiner, Tanuja Chitnis
Publikováno v:
Journal of Neuroinflammation, Vol 20, Iss 1, Pp 1-8 (2023)
Abstract Background Multiple sclerosis (MS) is a chronic demyelinating autoimmune disorder which may cause long-term disability. MicroRNA (miRNA) are stable, non-coding molecules that have been identified in our Comprehensive Longitudinal Investigati
Externí odkaz:
https://doaj.org/article/73a3adb279fc4ea89043543b396d0804
Autor:
Alicia Gonzalez-Martinez, Rohit Patel, Brian C. Healy, Hrishikesh Lokhande, Anu Paul, Shrishti Saxena, Mariann Polgar-Turcsanyi, Howard L. Weiner, Tanuja Chitnis
Publikováno v:
Journal of Neuroinflammation, Vol 20, Iss 1, Pp 1-8 (2023)
Abstract Background Multiple sclerosis (MS) is a disabling autoimmune demyelinating disorder affecting young people and causing significant disability. In the last decade, different microRNA (miRNA) expression patterns have been associated to several
Externí odkaz:
https://doaj.org/article/dc8a9c5060d94362ad72bda2d15d0d9a
Autor:
Yijun Zhao, Tong Wang, Riley Bove, Bruce Cree, Roland Henry, Hrishikesh Lokhande, Mariann Polgar-Turcsanyi, Mark Anderson, Rohit Bakshi, Howard L. Weiner, Tanuja Chitnis, SUMMIT Investigators
Publikováno v:
npj Digital Medicine, Vol 3, Iss 1, Pp 1-8 (2020)
Abstract The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitu
Externí odkaz:
https://doaj.org/article/3bd8a8242af34eb5b172cd47041ad140
Autor:
Yijun Zhao, Tong Wang, Riley Bove, Bruce Cree, Roland Henry, Hrishikesh Lokhande, Mariann Polgar-Turcsanyi, Mark Anderson, Rohit Bakshi, Howard L. Weiner, Tanuja Chitnis, SUMMIT Investigators
Publikováno v:
npj Digital Medicine, Vol 3, Iss 1, Pp 1-1 (2020)
A correction to this paper has been published: https://doi.org/10.1038/s41746-020-00361-9 .
Externí odkaz:
https://doaj.org/article/037a420db3ce4d699cf5e3f1997bfe74
Autor:
Alicia S. Chua, MS, Svetlana Egorova, MD, PhD, Mark C. Anderson, MS, Mariann Polgar-Turcsanyi, MS, Tanuja Chitnis, MD, Howard L. Weiner, MD, Charles R.G. Guttmann, MD, Rohit Bakshi, MD, Brian C. Healy, PhD
Publikováno v:
NeuroImage: Clinical, Vol 8, Iss C, Pp 606-610 (2015)
Magnetic resonance imaging (MRI) of the brain provides important outcome measures in the longitudinal evaluation of disease activity and progression in MS subjects. Two common measures derived from brain MRI scans are the brain parenchymal fraction (
Externí odkaz:
https://doaj.org/article/9dec622793484b72af157c39af30bcde
Autor:
Danielle Howard, Hrishikesh Lokhande, Brian Healy, Virginia De Las Heras, Sophie Arnould, Bonnie Glanz, Jonathan Zurawski, Mariann Polgar-Turcsanyi, Taylor Saraceno, Howard Weiner, Tanuja Chitnis
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0915d687cc184116d736433eb88af5f
https://doi.org/10.1212/wnl.0000000000202044
https://doi.org/10.1212/wnl.0000000000202044
Autor:
Gauruv Bose, Brian C. Healy, Shrishti Saxena, Fermisk Saleh, Anu Paul, Christian Barro, Hrishikesh A. Lokhande, Mariann Polgar-Turcsanyi, Mark Anderson, Bonnie I. Glanz, Charles R.G. Guttmann, Rohit Bakshi, Howard L. Weiner, Tanuja Chitnis
Publikováno v:
Multiple Sclerosis and Related Disorders. 74:104695
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dd9ad80e488e60fae6bf02d5a8fc5bf
https://doi.org/10.1016/j.msard.2023.104695
https://doi.org/10.1016/j.msard.2023.104695
Autor:
Sarah Conway, Shrishti Saxena, Clare Baecher-Allan, Rajesh Krishnan, Maria Houtchens, Bonnie Glanz, Taylor J Saraceno, Mariann Polgar-Turcsanyi, Gauruv Bose, Rohit Bakshi, Shamik Bhattacharyya, Kristin Galetta, Tamara Kaplan, Christopher Severson, Tarun Singhal, Lynn Stazzone, Jonathan Zurawski, Anu Paul, Howard L Weiner, Brian C Healy, Tanuja Chitnis
Publikováno v:
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9:205521732311651
Background There is limited knowledge about T cell responses in patients with multiple sclerosis (MS) after 3 doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine. Objectives Assess the SARS-CoV-2 spike antibody and T ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::372c06a434a073cc09f381c88170b73c
https://doi.org/10.1177/20552173231165196
https://doi.org/10.1177/20552173231165196
Autor:
Gauruv Bose, Brian C Healy, Christian Barro, Bonnie I Glanz, Hrishikesh A Lokhande, Mariann Polgar-Turcsanyi, Charles RG Guttmann, Rohit Bakshi, Howard L. Weiner, Tanuja Chitnis
Publikováno v:
Journal of neurology, neurosurgery, and psychiatry.
ObjectiveOlder age at multiple sclerosis (MS) onset has been associated with worse 10-year outcomes. However, disease duration often exceeds 10 years and age-related comorbidities may also contribute to disability. We investigated patients with>10 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e26e6b8f3e447ef85704140f0a0a2d
https://pubmed.ncbi.nlm.nih.gov/35953266
https://pubmed.ncbi.nlm.nih.gov/35953266